Data released May 9 by the Alliance for Regenerative Medicine (ARM) illustrates the growth of clinical activity where gene therapy is concerned.
ARM’s Quarterly Regenerative Medicine Global Data Report for the first quarter of 2019 showed 372 gene therapy clinical trials were in progress as of the end of Q1. Interestingly, a majority (217 or 58%) were studies in Phase II, followed by Phase I (123 or 33%), and Phase III (32 or 9%).
{iframe}https://www.genengnews.com/a-lists/25-up-and-coming-gene-therapies-of-2019/?utm_medium=newsletter&utm_source=GEN+News+Highlights+of+the+Week&utm_content=01&utm_campaign=GEN+News+Highlights+of+the+Week_20190525&oly_enc_id=1673D8247356B7U{/iframe}